Evidence map›Paper›PMID 28881649›Full record

ArticleOncotarget2017

Identification of deubiquitinase targets of isothiocyanates using SILAC-assisted quantitative mass spectrometry.

Ann P Lawson, Daniel W Bak, D Alexander Shannon, Marcus J C Long, Tushara Vijaykumar, Runhan Yu, Farid El Oualid, Eranthie Weerapana, Lizbeth Hedstrom

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Diarylcarbonates are a new class of deubiquitinating enzyme inhibitor.Bioorganic & medicinal chemistry letters · 2019
    Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Ann P LawsonDepartment of Biology, Brandeis University, Waltham, MA 02453-9110, USA.
Daniel W BakDepartment of Chemistry, Merkert Center, Boston College, Chestnut Hill, MA 02467-3860, USA.
D Alexander ShannonDepartment of Chemistry, Merkert Center, Boston College, Chestnut Hill, MA 02467-3860, USA.
Marcus J C LongGraduate Program in Biochemistry and Biophysics, Brandeis University, Waltham, MA 02453-9110, USA.
Tushara VijaykumarGraduate Program in Molecular and Cellular Biology, Brandeis University, Waltham, MA 02453-9110, USA.
Runhan YuDepartment of Chemistry, Brandeis University, Waltham, MA 02453-9110, USA.
Farid El OualidUbiQ, 1098 XH Amsterdam, The Netherlands.
Eranthie WeerapanaDepartment of Chemistry, Merkert Center, Boston College, Chestnut Hill, MA 02467-3860, USA.
Lizbeth HedstromDepartment of Biology, Brandeis University, Waltham, MA 02453-9110, USA.
Brandeis University · USBoston College · USCornell University · US

Funding

Inhibitor mediated protein degradationR01GM100921 · NIGMS · BRANDEIS UNIVERSITY · PI HEDSTROM, LIZBETH K. · 2012 to 2015
$1.2M
Investigating cysteine PTMs in living cellsR01GM117004 · NIGMS · BOSTON COLLEGE · PI WEERAPANA, ERANTHIE · 2016 to 2019
$1.2M
NIGMS NIH HHS R01 GM100921NIGMS NIH HHS R01 GM117004
6 · The paper itself

Abstract

Cruciferous vegetables such as broccoli and kale have well documented chemopreventative and anticancer effects that are attributed to the presence of isothiocyanates (ITCs). ITCs modulate the levels of many oncogenic proteins, but the molecular mechanisms of ITC action are not understood. We previously reported that phenethyl isothiocyanate (PEITC) inhibits two deubiquitinases (DUBs), USP9x and UCH37. DUBs regulate many cellular processes and DUB dysregulation is linked to the pathogenesis of human diseases including cancer, neurodegeneration, and inflammation. Using SILAC assisted quantitative mass spectrometry, here we identify 9 new PEITC-DUB targets: USP1, USP3, USP10, USP11, USP16, USP22, USP40, USP48 and VCPIP1. Seven of these PEITC-sensitive DUBs have well-recognized roles in DNA repair or chromatin remodeling. PEITC both inhibits USP1 and increases its ubiquitination and degradation, thus decreasing USP1 activity by two mechanisms. The loss of USP1 activity increases the level of mono-ubiquitinated DNA clamp PCNA, impairing DNA repair. Both the inhibition/degradation of USP1 and the increase in mono-ubiquitinated PCNA are new activities for PEITC that can explain the previously recognized ability of ITCs to enhance cancer cell sensitivity to cisplatin treatment. Our work also demonstrates that PEITC reduces the mono-ubiquityl histones H2A and H2B. Understanding the mechanism of action of ITCs should facilitate their use as therapeutic agents.

Indexed as

cisplatincruciferous vegetabledeubiquitinasePEITCUSP1

Identifiers

PMID28881649
PMCPMC5584250
OpenAlexW2607355686

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.